CBO Estimates Bill Blocking the Part B Drug Demo Will Cost $395 Million
Today, the Congressional Budget Office (CBO) released an estimate of the savings that could potentially be realized if CMS were to implement the proposed payment reductions and value-based purchasing tools for physician-administered drugs covered under Medicare Part B. The estimate was made within the context of H.R. 5122, “A bill to prohibit further action on the […]
Read More